Recent Company News

• 06:45 AM ET Dec 15, 2025
  

  Banks, luxury, travel/leisure the best performers; healthcare, retail and tech the main laggards:

• 04:04 AM ET Dec 15, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (63 total)

• 02:52 AM ET Dec 15, 2025
  

  StreetAccount Summary - European pre-market trading update

• 02:05 AM ET Dec 15, 2025
  

  Hikma Pharmaceuticals announces that Riad Mishlawi is today stepping down as CEO and from Hikma's board by mutual agreement (1516.0000p, 0)

• 04:13 PM ET Dec 08, 2025
  

  Hikma launches TYZAVAN" (vancomycin injection, USP) in the US

• 02:09 AM ET Dec 08, 2025
  

  Hikma launches TYZAVAN (vancomycin injection, USP) in the US (1594.0000p, 0)

• 08:02 AM ET Dec 06, 2025
  

  Shanghai Junshi Biosciences presents results on toripalimab at ESMO Asia Congress (HK$23.56, 0.00)

• 12:55 AM ET Nov 28, 2025
  

  Hikma Pharmaceuticals resumed buy at Peel Hunt; prior rating was buy (1570.0000p, 0)

• 11:00 AM ET Nov 22, 2025
  

  Transcript Intelligence: Hikma Pharmaceuticals at Jefferies Global Healthcare Conference

• 02:44 AM ET Nov 18, 2025
  

  Celltrion receives European Commission approval for Remsima IV liquid formulation (KRW 183800.0000, 0)